The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Chiasma, Inc. | Common | 16706W102 | 17,955 | 5,736,296 | SH | SOLE | 5,736,296 | 0 | 0 | ||
| Dyne Therapeutics, Inc. | Common | 26818M108 | 76,894 | 4,951,303 | SH | SOLE | 4,951,303 | 0 | 0 | ||
| Harpoon Therapeutics, Inc. | Common | 41358P106 | 67,745 | 3,238,306 | SH | SOLE | 3,238,306 | 0 | 0 | ||
| iTeos Therapeutics, Inc. | Common | 46565G104 | 126,694 | 3,706,663 | SH | SOLE | 3,706,663 | 0 | 0 | ||
| Oncorus, Inc. | Common | 68236R103 | 39,665 | 2,849,464 | SH | SOLE | 2,849,464 | 0 | 0 | ||
| Repare Therapeutics, Inc. | Common | 760273102 | 79,889 | 2,603,089 | SH | SOLE | 3,003,772 | 0 | 0 | ||
| Rhythm Pharmaceuticals, Inc. | Common | 76243J105 | 19,340 | 909,258 | SH | SOLE | 1,909,258 | 0 | 0 | ||
| TCR2 Therapeutics, Inc. | Common | 87808K106 | 89,443 | 4,050,865 | SH | SOLE | 4,050,865 | 0 | 0 | ||